Yıl: 2022 Cilt: 50 Sayı: 2 Sayfa Aralığı: 79 - 85 Metin Dili: İngilizce DOI: 10.5152/TJAR.2021.854 İndeks Tarihi: 16-06-2022

A1C as a Prognosticator of Perioperative Complications of Diabetes: A Narrative Review

Öz:
Hemoglobin A1c (A1C) or glycated hemoglobin reflects the levels of blood glucose during the previous 8–12 weeks duration. It also helps us to diagnose diabetes in some cases, during the preoperative screening, who were initially missed out. Although the number of patients with diabetes undergoing various surgeries has increased many times, the role of A1C as a predictor for the complications during the perioperative phase remains intriguing. This could be due to various factors such as lack of best shreds of evidence, various cut-off levels of target A1C, variations of the patient population, presence of other comorbid conditions, and so on. This narrative review article presents the role of A1C as a reflector of perioperative adverse events in various surgeries and discusses the controversies surrounding it. We searched “PubMed Central” database with search criteria of “hemoglobin A1c, glycated hemoglobin, and perioperative complications” with publication date from January 01, 2010, to January 31, 2020, and found a total of 214 articles. We included only the relevant articles to our topic and added a few more articles that we found as “secondary references” from those articles to suit the structured headings of our narrative review and made it a total of fifty. To our knowledge, the majority of the studies published on this topic are of the “Retrospective analysis” type of study, besides no narrative review article available to date in the literature. We suggest that assessment of A1C levels preoperatively can be used as a routine practice for major procedures in patients with diabetes and for patients who have persistent high glucose values during preoperative screening regardless of whether a diagnosis of diabetes is established or not. We found that a cut-off of 8% is acceptable for the majority of the surgical procedures. However, it is better to have a cut-off of 7% or lower for procedures such as spine and joint replacement surgeries, cardiac surgeries, and so on. Further prospective studies involving a large population preferably with a multicenter design would provide us more clarity on this topic.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Dickinson JK, Guzman SJ, Maryniuk MD, O’Brian CA, Kadohiro JK, Jackson RA, et al. The Use of Language in Diabe tes Care and Education. Diabetes Educ. 2017 Dec;43(6):551-564.
  • 2. Aldam P, Levy N, Hall GM. Perioperative management of diabetic patients: new controversies. Br J Anaesth. 2014;113(6): 906-909. [CrossRef]
  • 3. Underwood P, Askari R, Hurwitz S, Chamarthi B, Garg R. Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures. Diabetes Care. 2014;37(3):611-616. [CrossRef]
  • 4. Tennyson C, Lee R, Attia R. Is there a role for HbA1c in predicting mortality and morbidity outcomes after coronary artery bypass graft surgery? Interact Cardiovasc Thorac Surg. 2013;17(6):1000-1008. [CrossRef]
  • 5. Sato H, Carvalho G, Sato T, Lattermann R, Matsukawa T, Schricker T. The association of preoperative glycemic control, intraoperative insulin sensitivity, and outcomes after cardiac surgery. J Clin Endocrinol Metab. 2010;95(9):4338-4344. [CrossRef]
  • 6. Goodenough CJ, Liang MK, Nguyen MT, et al. Preoperative glycosylated hemoglobin and postoperative glucose together predict major complications after abdominal surgery. J Am Coll Surg. 2015;221(4):854-61.e1. [CrossRef]
  • 7. Jehan F, Khan M, Sakran JV, et al. Perioperative glycemic control and postoperative complications in patients undergoing emergency general surgery: what is the role of plasma hemoglobin A1c?. J Trauma Acute Care Surg. 2018;84(1):112-117. [CrossRef]
  • 8. Moitra VK, Greenberg J, Arunajadai S, Sweitzer BJ. The relationship between glycosylated hemoglobin and perioperative glucose control in patients with diabetes. Can J Anaesth. 2010;57(4):322-329.[CrossRef].
  • 9. Yang MH, Jaeger M, Baxter M, VanDenKerkhof E, van Vlymen J. Postoperative dysglycemia in elective non-diabetic surgical patients: a prospective observational study. Can J Anaesth. 2016;63(12):1319-1334. [CrossRef]
  • 10. Ramadan M, Abdelgawad A, Elshemy A, et al. Impact of elevated glycosylated hemoglobin on hospital outcome and 1year survival of primary isolated coronary artery bypass grafting patients. Egypt Heart J. 2018;70(2):113-118. [CrossRef].
  • 11. Faritous Z, Ardeshiri M, Yazdanian F, Jalali A, Totonchi Z, Azarfarin R. Hyperglycemia or high hemoglobin A1c: which one is more associated with morbidity and mortality after coronary artery bypass graft surgery? Ann Thorac Cardiovasc Surg. 2014;20(3):223-228. [CrossRef].
  • 12. Ouattara A, Lecomte P, Le Manach Y, et al. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology. 2005;103(4):687-694. [CrossRef]
  • 13. Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS. The association of diabetes and glucose control with surgicalsite infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol. 2001;22(10):607-612. [CrossRef]
  • 14. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004;109(12):1497-1502. [CrossRef]
  • 15. Masla M, Gottschalk A, Durieux ME, Groves DS. HbA1c and diabetes predict perioperative hyperglycemia and glycemic variability in on-pump coronary artery bypass graft patients. J Cardiothorac Vasc Anesth. 2011;25(5):799-803. [CrossRef]
  • 16. Knapik P, Cieśla D, Filipiak K, Knapik M, Zembala M. Prevalence and clinical significance of elevated preoperative glycosylated hemoglobin in diabetic patients scheduled for coronary artery surgery. Eur J Cardiothorac Surg. 2011;39(4):484-489. [CrossRef]
  • 17. Halkos ME, Puskas JD, Lattouf OM, et al. Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2008;136(3):631-640. [CrossRef]
  • 18. Cohen O, Dankner R, Chetrit A, et al. Multidisciplinary intervention for control of diabetes in patients undergoing coronary artery bypass graft (CABG). Cardiovasc Surg. 2003;11(3):195- 200. [CrossRef]
  • 19. Kuhl J, Sartipy U, Eliasson B, Nyström T, Holzmann MJ. Relationship between preoperative hemoglobin A1c levels and longterm mortality after coronary artery bypass grafting in patients with type 2 diabetes mellitus. Int J Cardiol. 2016;202:291-296. [CrossRef]
  • 20. Blake GJ, Pradhan AD, Manson JE, et al. Hemoglobin A1c level and future cardiovascular events among women. Arch Intern Med. 2004;164(7):757-761. [CrossRef]
  • 21. Pradhan AD, Rifai N, Buring JE, Ridker PM. HbA1c predicts diabetes but not cardiovascular disease in non-diabetic women. Am J Med. 2007;120(8):720-727. [CrossRef]
  • 22. Beattie WS, Wijeysundera DN. Perioperative cardiac biomarkers: the utility and timing. Curr Opin Crit Care. 2013;19(4):334- 341. [CrossRef]
  • 23. Wang TK, Woodhead A, Ramanathan T, Pemberton J. Relationship between diabetic variables and outcomes after coronary artery bypass grafting in diabetic patients. Heart Lung Circ. 2017;26(4):371-375. [CrossRef]
  • 24. Engoren M, Habib RH, Zacharias A, et al. The prevalence of elevated hemoglobin A1c in patients undergoing coronary artery bypass surgery. J Cardiothorac Surg. 2008;3:63. [CrossRef]
  • 25. Subramaniam B, Lerner A, Novack V, et al. Increased glycemic variability in patients with elevated preoperative HbA1c predicts adverse outcomes following coronary artery bypass grafting surgery. Anesth Analg. 2014;118(2):277-287. [CrossRef]
  • 26. Bardia A, Khabbaz K, Mueller A, et al. The association between preoperative hemoglobin A1c and postoperative glycemic variability on 30-day major adverse outcomes following isolated cardiac valvular surgery. Anesth Analg. 2017;124(1):16- 22. [CrossRef]
  • 27. Perna M, Romagnuolo J, Morgan K, Byrne TK, Baker M. Preoperative hemoglobin A1c and postoperative glucose control in outcomes after gastric bypass for obesity. Surg Obes Relat Dis. 2012;8(6):685-690. [CrossRef]
  • 28. O’Sullivan CJ, Hynes N, Mahendran B, et al. Haemoglobin A1c (HbA1c) in non-diabetic and diabetic vascular patients. Is HbA1c an independent risk factor and predictor of adverse outcome? Eur J Vasc Endovasc Surg. 2006;32(2):188-197. [CrossRef]
  • 29. Marchant MH Jr, Viens NA, Cook C, Vail TP, Bolognesi MP. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am. 2009;91(7):1621-1629. [CrossRef]
  • 30. Walid MS, Newman BF, Yelverton JC, Nutter JP, Ajjan M, Robinson JS Jr. Prevalence of previously unknown elevation of glycosylated hemoglobin in spine surgery patients and impact on length of stay and total cost. J Hosp Med. 2010;5(1):E10-E14. [CrossRef]
  • 31. Yang L, Sun Y, Li G, Liu J. Is hemoglobin A1c and perioperative hyperglycemia predictive of periprosthetic joint infection following total joint arthroplasty? A systematic review and meta-analysis. Medicine. 2017;96(51):(e8805). [CrossRef]
  • 32. Endara M, Masden D, Goldstein J, Gondek S, Steinberg J, Attinger C. The role of chronic and perioperative glucose management in high-risk surgical closures: a case for tighter glycemic control. Plast Reconstr Surg. 2013;132(4):996-1004. [CrossRef]
  • 33. Hikata T, Iwanami A, Hosogane N, et al. High preoperative hemoglobin A1c is a risk factor for surgical site infection after posterior thoracic and lumbar spinal instrumentation surgery. J Orthop Sci. 2014;19(2):223-228. [CrossRef]
  • 34. Gatti G, Perrotti A, Reichart D, et al. Glycated hemoglobin and risk of sternal wound infection after isolated coronary surgery. Circ J. 2016;81(1):36-43. [CrossRef]
  • 35. Elazary R, Abu-Gazala M, Ben-Porat T, Kedar A, Mintz Y. Early outcome after laparoscopic sleeve gastrectomy of type two diabetes mellitus patients with extremely elevated glycated hemoglobin (HbA1c). Int J Surg. 2013;11(9):869-871. [CrossRef]
  • 36. King JT Jr, Goulet JL, Perkal MF, Rosenthal RA. Glycemic control and infections in patients with diabetes undergoing noncardiac surgery. Ann Surg. 2011;253(1):158-165. [CrossRef]
  • 37. Rollins KE, Varadhan KK, Dhatariya K, Lobo DN. Systematic review of the impact of HbA1c on outcomes following surgery in patients with diabetes mellitus. Clin Nutr. 2016;35(2):308-316. [CrossRef]
  • 38. Finger B, Brase J, He J, Gibson WJ, Wirtz K, Flynn BC. Elevated hemoglobin A1c is associated with lower socioeconomic position and increased postoperative infections and longer hospital stay after cardiac surgical procedures. Ann Thorac Surg. 2017;103(1):145-151. [CrossRef]
  • 39. Almogati JG, Ahmed EO. Glycated hemoglobin as a predictor of the length of hospital stay in patients following coronary bypass graft surgery in the Saudi population. Braz J Cardiovasc Surg. 2019;34(1):28-32. [CrossRef].
  • 40. Avci BS, Saler T, Avci A, et al. Relationship between morbidity and mortality and HbA1c levels in diabetic patients undergoing major surgery. J Coll Physicians Surg Pak. 2019;29(11):1043-1047. [CrossRef]
  • 41. Jones CE, Graham LA, Morris MS, et al. Association between preoperative hemoglobin A1c levels, postoperative hyperglycemia, and readmissions following gastrointestinal surgery. JAMA Surg. 2017;152(11):1031-1038. [CrossRef]
  • 42. Hudson CCC, Welsby IJ, Phillips-Bute B, et al. Glycosylated hemoglobin levels and outcome in non-diabetic cardiac surgery patients. Can J Anaesth. 2010;57(6):565-572. [CrossRef]
  • 43. Cheisson G, Jacqueminet S, Cosson E, et al. Perioperative management of adult diabetic patients: preoperative period. Anaesth Crit Care Pain Med. 2018;37(suppl 1):S9-S19. [CrossRef]
  • 44. Joint British Diabetes Societies for Inpatient Care. Management of Adults with Diabetes Undergoing Surgery and Elective Procedures: Improving Standards. Summary. 2016. Available at: https ://ww w.dia betes .org. uk/re sourc es-s3 /2017 -09/S urgic al%20 guide line% 20201 5%20- %20su mmary %20FI NAL%2 0amen ded%2 0Mar% 20201 6.pdf .
  • 45. Mendez CE, Wainaina N, Walker RJ, et al. Preoperative diabetes optimization program. Clin Diabetes. 2018;36(1):68-71. [CrossRef]
  • 46. Levy N, Dhatariya K. Pre‐operative optimisation of the surgical patient with diagnosed and undiagnosed diabetes: a practical review. Anaesthesia. 2019;74(suppl 1):58-66. [CrossRef]
  • 47. Gabriel RA, Hylton DJ, Burton BN, Schmidt UH, Waterman RS. The association of preoperative haemoglobin A1c with 30-day postoperative surgical site infection following non-cardiac surgery. J Perioper Pract. 2019;30(10):320-325. [CrossRef].
  • 48. Wachsmann A, Maga M, Schönborn M, et al. Impact of preoperative glycated haemoglobin A1c level on 1-year outcomes of endovascular treatment in patients with critical limb ischemia in the course of diabetes mellitus. Folia Med Cracov. 2019;59(1):49-60.
  • 49. Robich MP, Iribarne A, Leavitt BJ, et al. Intensity of glycemic control affects long-term survival after coronary artery bypass graft surgery. Ann Thorac Surg. 2019;107(2):477-484. [CrossRef]
  • 50. Kocogulları CU, Kunt AT, Aksoy R, et al. Hemoglobin A1c levels predicts acute kidney injury after coronary artery bypass surgery in non-diabetic patients. Braz J Cardiovasc Surg. 2017;32(2):83-89. [CrossRef]
APA M S R, Parida S, S A, Selvam P (2022). A1C as a Prognosticator of Perioperative Complications of Diabetes: A Narrative Review. , 79 - 85. 10.5152/TJAR.2021.854
Chicago M S Raghuraman,Parida Satyen,S Adinarayanan,Selvam Priyanka A1C as a Prognosticator of Perioperative Complications of Diabetes: A Narrative Review. (2022): 79 - 85. 10.5152/TJAR.2021.854
MLA M S Raghuraman,Parida Satyen,S Adinarayanan,Selvam Priyanka A1C as a Prognosticator of Perioperative Complications of Diabetes: A Narrative Review. , 2022, ss.79 - 85. 10.5152/TJAR.2021.854
AMA M S R,Parida S,S A,Selvam P A1C as a Prognosticator of Perioperative Complications of Diabetes: A Narrative Review. . 2022; 79 - 85. 10.5152/TJAR.2021.854
Vancouver M S R,Parida S,S A,Selvam P A1C as a Prognosticator of Perioperative Complications of Diabetes: A Narrative Review. . 2022; 79 - 85. 10.5152/TJAR.2021.854
IEEE M S R,Parida S,S A,Selvam P "A1C as a Prognosticator of Perioperative Complications of Diabetes: A Narrative Review." , ss.79 - 85, 2022. 10.5152/TJAR.2021.854
ISNAD M S, Raghuraman vd. "A1C as a Prognosticator of Perioperative Complications of Diabetes: A Narrative Review". (2022), 79-85. https://doi.org/10.5152/TJAR.2021.854
APA M S R, Parida S, S A, Selvam P (2022). A1C as a Prognosticator of Perioperative Complications of Diabetes: A Narrative Review. Turkish Journal of Anaesthesiology and Reanimation, 50(2), 79 - 85. 10.5152/TJAR.2021.854
Chicago M S Raghuraman,Parida Satyen,S Adinarayanan,Selvam Priyanka A1C as a Prognosticator of Perioperative Complications of Diabetes: A Narrative Review. Turkish Journal of Anaesthesiology and Reanimation 50, no.2 (2022): 79 - 85. 10.5152/TJAR.2021.854
MLA M S Raghuraman,Parida Satyen,S Adinarayanan,Selvam Priyanka A1C as a Prognosticator of Perioperative Complications of Diabetes: A Narrative Review. Turkish Journal of Anaesthesiology and Reanimation, vol.50, no.2, 2022, ss.79 - 85. 10.5152/TJAR.2021.854
AMA M S R,Parida S,S A,Selvam P A1C as a Prognosticator of Perioperative Complications of Diabetes: A Narrative Review. Turkish Journal of Anaesthesiology and Reanimation. 2022; 50(2): 79 - 85. 10.5152/TJAR.2021.854
Vancouver M S R,Parida S,S A,Selvam P A1C as a Prognosticator of Perioperative Complications of Diabetes: A Narrative Review. Turkish Journal of Anaesthesiology and Reanimation. 2022; 50(2): 79 - 85. 10.5152/TJAR.2021.854
IEEE M S R,Parida S,S A,Selvam P "A1C as a Prognosticator of Perioperative Complications of Diabetes: A Narrative Review." Turkish Journal of Anaesthesiology and Reanimation, 50, ss.79 - 85, 2022. 10.5152/TJAR.2021.854
ISNAD M S, Raghuraman vd. "A1C as a Prognosticator of Perioperative Complications of Diabetes: A Narrative Review". Turkish Journal of Anaesthesiology and Reanimation 50/2 (2022), 79-85. https://doi.org/10.5152/TJAR.2021.854